Navigation Links
Attorney Wayne Keown Joins Preti Flaherty's Portland, ME Office

Today Preti Flaherty announced that Wayne Keown has joined the firm as Of Counsel in its Intellectual Property Group and will be practicing primarily out of its Portland office. Keown is a highly-experienced patent prosecutor with a strong background in Pharma/Biotech matters.

Portland, Maine (Vocus) January 13, 2010 -- Today Preti Flaherty announced that Wayne Keown has joined the firm as Of Counsel in its Intellectual Property Group and will be practicing primarily out of its Portland office. Keown is a highly-experienced patent prosecutor with a strong background in Pharma/Biotech matters. He brings 20 years of experience in prosecution, litigation, due diligence, opinion work, licensing and portfolio development and management to Preti Flaherty. He has extensive experience in U.S. and European patent office and court proceedings, Pharma/Biotech collaboration agreements and public and private investments.

Keown holds a Ph.D. in Genetics and brings his extensive knowledge of biology, pharmaceuticals, chemistry and medical technology to his patent law practice.

According to attorney Alfred Frawley, Chair of Preti Flaherty’s Intellectual Property Group, “Wayne is an acknowledged leader in the Biotech IP field. His experience as a patent prosecutor, and his unique skill set will strengthen and diversify the resources of our Intellectual Property Group. We are very pleased to add his expertise to our team.”

Prior to joining Preti Flaherty, Keown’s legal career included founding a small patent law firm in Massachusetts and practicing patent law with Hale and Dorr LLP as a senior partner. He also served as sole in-house patent counsel to Hybridon, Inc., where he developed and managed a large patent portfolio and negotiated Pharma/Biotech collaboration and research agreements.

Keown is admitted to practice only in Massachusetts. He is a member of the American Intellectual Property Law Association and the Boston Patent Law Association. He is a 1992 graduate of John Marshall School of Law and earned his Ph.D. in Genetics from the University of Illinois in 1989. He earned his B.S. in Microbiology from Indiana University.

About Preti Flaherty

Preti Flaherty has offices in Portland and Augusta, Maine, Concord, N.H., Boston, Mass, Bedminster, N.J., and Washington, D.C. With more than 85 attorneys, the firm counsels clients in the areas of business law, climate strategy, energy, environmental, estate planning, health care, intellectual property, labor and employment, legislative and regulatory, litigation, technology and telecommunications. More information about the firm is available at

# # #

Read the full story at

Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved  

Related biology technology :

1. CryoLife Responds to Inaccurate Assertions from Plaintiffs Attorney
2. Twenty-One Brinks Hofer Gilson & Lione Attorneys Named 2008 Illinois Super Lawyers
3. Life Sciences Industry Reaches Crossroad Say Noted Pillsbury Attorneys
4. Healthcare Industry Faces Mounting Pressure to Prevent On-The-Job Violence, Says Veteran Safety and Health Attorney
5. Brinks Hofer Gilson & Lione Expands to High-Tech Raleigh/Durham Area; Adds Accomplished Patent Attorneys to Its New Office
6. Miami Beach Real Estate Attorney Announces Services to Assist Chinese and other International Real Estate Investors Purchase Discount Florida Homes
7. Three Attorneys Rejoin McKenna Long & Aldridge
8. Miami Beach Real Estate Attorney Opens Miami Real Estate Brokerage for International Luxury Miami Beach Condo Buyers From Distressed Sellers
9. Patent Attorney John Rizvi Speaks at FIME International Medical Expo
10. Trusted LASIK Surgeons Welcomes Dallas LASIK Eye Surgery Specialist Dr. R. Wayne Bowman to its LASIK Directory
11. WellSpring Pharmaceutical Corp. Announces Hire of Wayne Miller as Vice President, Sales & Marketing, Consumer Brands
Post Your Comments:
Related Image:
Attorney Wayne Keown Joins Preti Flaherty's Portland, ME Office
(Date:11/24/2015)... SUNNYVALE, Calif. , Nov. 24, 2015 ... executives will be speaking at the following conference, and ... New York, NY      Tuesday, December 1, ... New York, NY      Tuesday, December 1, ...      Piper Jaffray Healthcare Conference, New York, NY ...
(Date:11/24/2015)... /CNW/ - iCo Therapeutics ("iCo" or "the Company") (TSX-V: ... the quarter ended September 30, 2015. Amounts, unless ... presented under International Financial Reporting Standards ("IFRS"). ... Andrew Rae , President & CEO of ... only value enriching for this clinical program, but ...
(Date:11/24/2015)... Florida (PRWEB) , ... November 24, 2015 , ... ... biggest event of the year and one of the premier annual events for ... and ran from 8–11 November 2015, where ISPE hosted the largest number of ...
(Date:11/24/2015)... 24, 2015  Clintrax Global, Inc., a worldwide provider of clinical ... today announced that the company has set a new quarterly earnings ... on quarter growth posted for Q3 of 2014 to Q3 of ... Mexico , with the establishment of an ... --> United Kingdom and Mexico ...
Breaking Biology Technology:
(Date:11/17/2015)... Paris , qui s,est tenu ... Paris , qui s,est tenu du 17 au ... l,innovation biométrique, a inventé le premier scanner couplé, qui ... même surface de balayage. Jusqu,ici, deux scanners étaient nécessaires, ... digitales. Désormais, un seul scanner est en mesure de ...
(Date:11/17/2015)... SOUTH EASTON, Mass. , Nov. 17, 2015 /PRNewswire/ ... "Company"), a leader in the development and sale of ... to the worldwide life sciences industry, today announced it ... closing of its $5 million Private Placement (the "Offering"), ... Offering to $4,025,000.  One or more additional closings are ...
(Date:11/12/2015)... Nov. 12, 2015  A golden retriever that stayed ... dystrophy (DMD) has provided a new lead for treating ... the Broad Institute of MIT and Harvard and the ... . Cell, pinpoints a protective ... the disease,s effects. The Boston Children,s lab of ...
Breaking Biology News(10 mins):